Bespoke Extracts（BSPK）株式概要Bespoke Extracts, Inc.は、その子会社であるBespoke Extracts Colorado, LLCとともに、米国で巻き済みマリファナ・シガレットを製造・販売している。 詳細BSPK ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6報酬過去5年間の収益は年間17.7%増加しました。 リスク分析マイナスの株主資本 意味のある時価総額がありません ( $2M )キャッシュランウェイが1年未満である 株式の流動性は非常に低い +1 さらなるリスクすべてのリスクチェックを見るBSPK Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.1995.2% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-7m20m2016201920222025202620282031Revenue US$20.1mEarnings US$2.9mAdvancedSet Fair ValueView all narrativesBespoke Extracts, Inc. 競合他社60 Degrees PharmaceuticalsSymbol: NasdaqCM:SXTPMarket cap: US$3.7mTarget GroupSymbol: OTCPK:CBDYMarket cap: US$1.1mValeo PharmaSymbol: OTCPK:VPHI.FMarket cap: US$4.6mCannaPharmaRXSymbol: OTCPK:CPMDMarket cap: US$2.0m価格と性能株価の高値、安値、推移の概要Bespoke Extracts過去の株価現在の株価US$0.1952週高値US$0.3552週安値US$0.067ベータ0.181ヶ月の変化-17.92%3ヶ月変化-32.99%1年変化83.29%3年間の変化70.50%5年間の変化-80.34%IPOからの変化-99.90%最新ニュースお知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.お知らせ • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.最新情報をもっと見るRecent updatesお知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.お知らせ • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 02Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 04/01/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/15/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 13Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million on August 12, 2022. Upon closing, Bespoke will issue 125,000,000 shares of common stock in exchange for the assets of Osiris. 50 percent of these shares will be subject to a six-month lockup period and 50 percent will be subject to a twelve-month lockup period. Bespoke has also agreed to assume up to $125,000 of equipment-based financing following the transaction. Bespoke will also be entering into leases for the Aspen Dispensary, the Glenwood Cultivation Facility and the Glenwood Dispensary. The transaction has been approved by the boards of directors of Bespoke and the members of Osiris and is subject to customary closing conditions, including approvals from Colorado regulatory authorities. The transaction is expected to close in the fourth calendar quarter of 2022.お知らせ • Jan 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Dec 03Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million on December 2, 2021. Total consideration is to be paid 100% in Bespoke common shares. Bespoke will issue 2.5 million shares as a deposit, and an additional $0.15 of shares at closing according to the daily volume weighted average price of Bespoke common stock for the 30 consecutive trading days prior to closing. The proposed transaction has been unanimously approved by the Bespoke board of directors and is expected to close upon receipt of state and local regulatory approvals and satisfaction of other customary closing conditions.お知らせ • Nov 30Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/29/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Apr 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 04/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Feb 26Bespoke Extracts, Inc. announced that it has received $0.5 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a securities purchase agreement for a private placement of 10,000,000 shares at an issue price of $0.05 per share for gross proceeds $500,000 on February 25, 2021. The transaction included participation from an accredited investor.お知らせ • Feb 06Bespoke Extracts Welcomes Trend Expert Carly Stojsic as New Director of MarketingBespoke Extracts, Inc. announced the appointment of industry trend expert Carly Stojsic as the company’s new Director of Marketing. Reporting directly to Bespoke CEO Danny Pollack, Stojsic will lead, guide and implement all aspects of the Company’s brand-building and product marketing strategies. For the past 15 years, Stojsic has applied her well-known and seasoned trend expertise to specialty and mass market brands operating within the lifestyle and retail industries. Her acumen in trend forecasting, presentation, unearthing innovative insights, achieving experiential customer engagement, and delivering impactful content marketing and market education, across all categories, has earned her distinction as a much sought after speaker and marketing advisor. For six years, Stojsic served as Market Editor and Senior Trend Specialist for WGSN, the global authority on consumer and design trends. In 2017, she was invited to present her macro consumer trend forecast, titled “The Builds and Collapses of Dimensions on the Trendscape” at MIT in Cambridge, Massachusetts. She has worked with brands that have included Gucci, Miu Miu (Prada Group), HBC, Joe Fresh, P&G, Starbucks and Walmart, among many others. Her consultative work in the cannabis space has included projects with 48North, Dosist, Calyx Wellness and various retailers, as well as brand management with Khalifa Kush Enterprises (Supreme Cannabis Company). Stojsic is perhaps best known in the industry for her ability to capture and captivate audiences with mind-blowing content.お知らせ • Jan 22Bespoke Extracts, Inc. announced that it has received $0.1 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced that it has entered into a securities purchase agreement for a private placement of 2,000,000 common shares at an issue price of $0.05 per share for gross proceeds of $100,000 on January 21, 2021. The transaction included participation from Chief Executive Officer of the company, Danil Pollack. The security issued is subject to hold period.お知らせ • Jan 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jan 14Bespoke Extracts, Inc. Announces Its Plan to Reintroduce Umf® (Unique Manuka Factor) 15+ Rated Manuka Honey-Infused Cbd FormulationsBespoke Extracts, Inc. announced its plan to reintroduce UMF® (Unique Manuka Factor) 15+ rated Manuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.お知らせ • Dec 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/30/2020, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 25Bespoke Extracts, Inc. Introduces New Premium Product Line-Up of Seven Special CBD FormulationsBespoke Extracts, Inc. introduced a new line of specially-formulated, premium quality, hemp-derived CBD products now available for purchase in its ecommerce store. It introduced a new premium product line-up of seven special CBD formulations created specifically for “Women” and “Sport.” Bespoke’s products have been crafted so an individual can precisely tailor their use of its hemp-derived CBD tinctures and softgels to address their personal wellness objectives.お知らせ • Oct 20Bespoke Extracts, Inc. Appoints Yaniv Rozen as Chief Operating OfficerOn October 13, 2020, Yaniv Rozen was appointed chief operating officer of Bespoke Extracts, Inc. Mr. Rozen has been working as a consultant for start-up companies in the e-commerce industry for the last 5 years. On October 13, 2020, the company entered into a consulting agreement with Mr. Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen may engage in other business activities while serving as the Company’s chief operating officer.お知らせ • Sep 29Bespoke Extracts, Inc. announced that it has received $0.15 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a private placement of a non-convertible promissory note in the principal amount of $150,000 on August 31, 2020. The transaction included participation from chief executive officer of the company, Danil Pollack. The note does not bear interest and matures on November 30, 2020.株主還元BSPKUS PharmaceuticalsUS 市場7D0%1.4%-0.3%1Y83.3%34.5%24.1%株主還元を見る業界別リターン: BSPK過去 1 年間で34.5 % の収益を上げたUS Pharmaceuticals業界を上回りました。リターン対市場: BSPK過去 1 年間で24.1 % の収益を上げたUS市場を上回りました。価格変動Is BSPK's price volatile compared to industry and market?BSPK volatilityBSPK Average Weekly Movementn/aPharmaceuticals Industry Average Movement9.9%Market Average Movement7.2%10% most volatile stocks in US Market16.2%10% least volatile stocks in US Market3.2%安定した株価: BSPKの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のBSPKのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト1988n/aMichael Feinsodbespokeextracts.comBespoke Extracts, Inc.は、子会社のBespoke Extracts Colorado, LLCとともに、米国で巻きたばこを製造・販売している。同社はFresh Joints、Box-O-Joints、Wee Jointsのブランド名で大麻消費者向けパッケージ商品を所有、製造、販売しており、大麻入り製品の製造施設も運営している。また、マリファナ煎じ製品の製造施設も運営している。同社は以前はDiMi Telematics International, Inc.として知られ、2017年3月にBespoke Extracts, Inc.に社名を変更した。1988年に設立され、コロラド州オーロラに本社を置く。もっと見るBespoke Extracts, Inc. 基礎のまとめBespoke Extracts の収益と売上を時価総額と比較するとどうか。BSPK 基礎統計学時価総額US$2.11m収益（TTM）-US$730.56k売上高(TTM)US$1.42m1.5xP/Sレシオ-2.9xPER（株価収益率BSPK は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計BSPK 損益計算書（TTM）収益US$1.42m売上原価US$751.35k売上総利益US$671.70kその他の費用US$1.40m収益-US$730.56k直近の収益報告Sep 30, 2025次回決算日該当なし一株当たり利益（EPS）-0.065グロス・マージン47.20%純利益率-51.34%有利子負債／自己資本比率-55.7%BSPK の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/18 10:42終値2026/05/06 00:00収益2025/09/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bespoke Extracts, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.
お知らせ • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.
お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.
お知らせ • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.
お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 02Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 04/01/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/15/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 13Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million on August 12, 2022. Upon closing, Bespoke will issue 125,000,000 shares of common stock in exchange for the assets of Osiris. 50 percent of these shares will be subject to a six-month lockup period and 50 percent will be subject to a twelve-month lockup period. Bespoke has also agreed to assume up to $125,000 of equipment-based financing following the transaction. Bespoke will also be entering into leases for the Aspen Dispensary, the Glenwood Cultivation Facility and the Glenwood Dispensary. The transaction has been approved by the boards of directors of Bespoke and the members of Osiris and is subject to customary closing conditions, including approvals from Colorado regulatory authorities. The transaction is expected to close in the fourth calendar quarter of 2022.
お知らせ • Jan 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Dec 03Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million on December 2, 2021. Total consideration is to be paid 100% in Bespoke common shares. Bespoke will issue 2.5 million shares as a deposit, and an additional $0.15 of shares at closing according to the daily volume weighted average price of Bespoke common stock for the 30 consecutive trading days prior to closing. The proposed transaction has been unanimously approved by the Bespoke board of directors and is expected to close upon receipt of state and local regulatory approvals and satisfaction of other customary closing conditions.
お知らせ • Nov 30Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/29/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Apr 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 04/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Feb 26Bespoke Extracts, Inc. announced that it has received $0.5 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a securities purchase agreement for a private placement of 10,000,000 shares at an issue price of $0.05 per share for gross proceeds $500,000 on February 25, 2021. The transaction included participation from an accredited investor.
お知らせ • Feb 06Bespoke Extracts Welcomes Trend Expert Carly Stojsic as New Director of MarketingBespoke Extracts, Inc. announced the appointment of industry trend expert Carly Stojsic as the company’s new Director of Marketing. Reporting directly to Bespoke CEO Danny Pollack, Stojsic will lead, guide and implement all aspects of the Company’s brand-building and product marketing strategies. For the past 15 years, Stojsic has applied her well-known and seasoned trend expertise to specialty and mass market brands operating within the lifestyle and retail industries. Her acumen in trend forecasting, presentation, unearthing innovative insights, achieving experiential customer engagement, and delivering impactful content marketing and market education, across all categories, has earned her distinction as a much sought after speaker and marketing advisor. For six years, Stojsic served as Market Editor and Senior Trend Specialist for WGSN, the global authority on consumer and design trends. In 2017, she was invited to present her macro consumer trend forecast, titled “The Builds and Collapses of Dimensions on the Trendscape” at MIT in Cambridge, Massachusetts. She has worked with brands that have included Gucci, Miu Miu (Prada Group), HBC, Joe Fresh, P&G, Starbucks and Walmart, among many others. Her consultative work in the cannabis space has included projects with 48North, Dosist, Calyx Wellness and various retailers, as well as brand management with Khalifa Kush Enterprises (Supreme Cannabis Company). Stojsic is perhaps best known in the industry for her ability to capture and captivate audiences with mind-blowing content.
お知らせ • Jan 22Bespoke Extracts, Inc. announced that it has received $0.1 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced that it has entered into a securities purchase agreement for a private placement of 2,000,000 common shares at an issue price of $0.05 per share for gross proceeds of $100,000 on January 21, 2021. The transaction included participation from Chief Executive Officer of the company, Danil Pollack. The security issued is subject to hold period.
お知らせ • Jan 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jan 14Bespoke Extracts, Inc. Announces Its Plan to Reintroduce Umf® (Unique Manuka Factor) 15+ Rated Manuka Honey-Infused Cbd FormulationsBespoke Extracts, Inc. announced its plan to reintroduce UMF® (Unique Manuka Factor) 15+ rated Manuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.
お知らせ • Dec 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/30/2020, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 25Bespoke Extracts, Inc. Introduces New Premium Product Line-Up of Seven Special CBD FormulationsBespoke Extracts, Inc. introduced a new line of specially-formulated, premium quality, hemp-derived CBD products now available for purchase in its ecommerce store. It introduced a new premium product line-up of seven special CBD formulations created specifically for “Women” and “Sport.” Bespoke’s products have been crafted so an individual can precisely tailor their use of its hemp-derived CBD tinctures and softgels to address their personal wellness objectives.
お知らせ • Oct 20Bespoke Extracts, Inc. Appoints Yaniv Rozen as Chief Operating OfficerOn October 13, 2020, Yaniv Rozen was appointed chief operating officer of Bespoke Extracts, Inc. Mr. Rozen has been working as a consultant for start-up companies in the e-commerce industry for the last 5 years. On October 13, 2020, the company entered into a consulting agreement with Mr. Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen may engage in other business activities while serving as the Company’s chief operating officer.
お知らせ • Sep 29Bespoke Extracts, Inc. announced that it has received $0.15 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a private placement of a non-convertible promissory note in the principal amount of $150,000 on August 31, 2020. The transaction included participation from chief executive officer of the company, Danil Pollack. The note does not bear interest and matures on November 30, 2020.
